Financial Snapshot: Analyzing Vor Biopharma Inc (VOR)’s Key Ratio Metrics

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

The closing price of Vor Biopharma Inc (NASDAQ: VOR) was $0.62 for the day, down -13.59% from the previous closing price of $0.72. In other words, the price has decreased by -$13.59 from its previous closing price. On the day, 0.51 million shares were traded. VOR stock price reached its highest trading level at $0.72 during the session, while it also had its lowest trading level at $0.62.

Ratios:

Our analysis of VOR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.19 and its Current Ratio is at 5.19. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on July 26, 2022, initiated with a Outperform rating and assigned the stock a target price of $18.

On April 27, 2022, Goldman started tracking the stock assigning a Neutral rating and target price of $6.

On December 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $26.H.C. Wainwright initiated its Buy rating on December 17, 2021, with a $26 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 13 ’25 when Attar Eyal C. sold 2,227 shares for $1.42 per share. The transaction valued at 3,162 led to the insider holds 126,625 shares of the business.

EYAL ATTAR bought 2,227 shares of VOR for $3,073 on Feb 13 ’25. On Feb 10 ’25, another insider, Attar Eyal C., who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,554 shares for $1.37 each. As a result, the insider received 3,499 and left with 128,852 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VOR now has a Market Capitalization of 77408240 and an Enterprise Value of 17311960.

Stock Price History:

The Beta on a monthly basis for VOR is -0.21, which has changed by -0.70476186 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, VOR has reached a high of $2.43, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -45.47%, while the 200-Day Moving Average is calculated to be -37.02%.

Shares Statistics:

VOR traded an average of 502.09K shares per day over the past three months and 233000 shares per day over the past ten days. A total of 124.78M shares are outstanding, with a floating share count of 76.79M. Insiders hold about 38.50% of the company’s shares, while institutions hold 43.00% stake in the company. Shares short for VOR as of 1741910400 were 1328758 with a Short Ratio of 2.65, compared to 1739491200 on 1437942. Therefore, it implies a Short% of Shares Outstanding of 1328758 and a Short% of Float of 1.4199998999999999.

Most Popular